Rhes expression in pancreatic β-cells is regulated by efaroxan in a calcium-dependent process
- 20 October 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 349 (2) , 809-815
- https://doi.org/10.1016/j.bbrc.2006.08.102
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Two Generations of Insulinotropic Imidazoline CompoundsDiabetes, 2002
- The Imidazoline RX871024 Stimulates Insulin Secretion in Pancreatic β-Cells from Mice Deficient in KATP Channel FunctionBiochemical and Biophysical Research Communications, 2001
- Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposureBiochemical Pharmacology, 2001
- Characterization of a KATP Channel—Independent Pathway Involved in Potentiation of Insulin Secretion by EfaroxanDiabetes, 2001
- Imidazolines and Pancreatic Hormone SecretionaAnnals of the New York Academy of Sciences, 1999
- Affinity isolation of imidazoline binding proteins from rat brain using 5‐amino‐efaroxan as a ligandFEBS Letters, 1999
- Phentolamine block of K ATP channels is mediated by Kir6.2Proceedings of the National Academy of Sciences, 1997
- Role of α2-Adrenoceptors and Imidazoline-Binding Sites in the Control of Insulin SecretionClinical Science, 1993
- Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding siteEuropean Journal of Pharmacology, 1993
- Imidazoline antagonists of α2‐adrenoceptors increase insulin release in vitro by inhibiting ATP‐sensitive K+ channels in pancreatic β‐cellsBritish Journal of Pharmacology, 1992